Trial Profile

Absence of bismuth accumulation in patients prescribed pylera in real life setting

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 14 May 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tripotassium dicitrato bismuthate/tetracycline/metronidazole (Primary)
Indications Helicobacter pylori infections
Focus Adverse reactions; Pharmacokinetics
Acronyms SAPHARY

Most Recent Events

08 May 2019 Results published in the Drug Safety
22 Sep 2017 New trial record
30 Aug 2017 Results presented at the 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com